Ziprasidone in the Psychosis Prodrome

Conditions

Psychosis Prodrome

What is the purpose of this trial?

This study aims to determine whether ziprasidone is superior to placebo over 24 weeks for patients with the psychosis prodrome.



Participation Guidelines

Age:
16 Years - 40 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
March 2008
Last Updated:
January 13, 2010
Study HIC#:
0801003386

Clinicaltrials.gov ID: NCT00635700